More Proteomics International Laboratories Ltd. news
Proteomics International Laboratories Ltd.ASX: PIQ

PromarkerD IVD successfully developed and validated

Sep 17, 2019 at 4:30 AM EDT · Issued by Proteomics International Laboratories Ltd.

Filed with ASX · Sep 17, 2019 at 4:30 AM EDT

On 6ix: 6ix.com/news/promarkerd-ivd-successfully-developed-and-validated

Proteomics Intl Labs Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Proteomics International Laboratories Ltd. on 6ix

Earlier from Proteomics International Laboratories

  • PromarkerD diabetic kidney disease test launched in SpainSep 13, 2019
  • PromarkerD test ready for launch in EuropeSep 12, 2019
  • Appendix 4C - June 2019 Quarterly ReportJul 30, 2019
  • Proteomics secures contracts for pharmacokinetic analysisJul 25, 2019
  • Appendix 4C - March 2019 Quarterly ReportApr 23, 2019

Later from Proteomics International Laboratories

  • Appendix 4C - September 2019 Quarterly ReportOct 30, 2019
  • CE Mark for predictive test for diabetic kidney diseaseNov 11, 2019
  • Proteomics raises $3m in heavily oversubscribed PlacementNov 14, 2019
  • Partnership provides funding for cutting-edge facilityNov 25, 2019
  • CE Mark for PromarkerD Hub predictive software for DKDJan 13, 2020
All Proteomics International Laboratories news releases↗

Follow Proteomics International Laboratories into a list and get an email when it puts out news.

Follow Proteomics International Laboratories
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer